INTRODUCTION
Multipotent mesenchymal stromal cells (MSCs) have been defined in culture as nonhematopoietic, plastic-adherent, colony-forming cells, referred to as colony-forming unit-fibroblasts (CFU-Fs) , that can differentiate into osteogenic, chondrogenic, and adipogenic progeny (Bianco et al., 2008; Friedenstein et al., 1970; Horwitz et al., 2005; Pittenger et al., 1999) . A fundamental question concerns the identity of the cells that form CFUFs in culture and their physiological function in vivo.
In vivo, MSCs are often perivascular (Crisan et al., 2008; Sacchetti et al., 2007) . In human tissues, MSCs have been prospectively identified based on the lack of expression of endothelial and hematopoietic markers along with positive expression for CD146 (Sacchetti et al., 2007) or CD146 with platelet-derived growth factor receptor b (PDGFRb), CD106, NG2, or some combination thereof (Chou et al., 2012; Crisan et al., 2008; Schwab and Gargett, 2007) . CD146 + MSCs from human bone marrow form osteogenic, chondrogenic, and adipogenic cells in culture and give rise to bone upon transplantation in vivo, forming bony ossicles that become invested with hematopoietic bone marrow (Sacchetti et al., 2007) . The CD146 + cells persist around sinusoidal blood vessels in the ossicles and express HSC niche factors. Ectopic bones that become invested with bone marrow can also be formed by CD105 +
Thy1
À mesenchymal cells from fetal mouse bones (Chan et al., 2009) . Although much has been learned about the localization and developmental potential of MSCs, limitations in the ability to fate-map these cells in vivo have hindered our understanding of their normal physiological function. Mouse MSCs have been prospectively identified based on the lack of expression of hematopoietic and endothelial markers and positive expression of PDGFRa (Morikawa et al., 2009; Omatsu et al., 2010; Park et al., 2012 
Ter119
À cells that express high levels of Cxcl12, also known as CXCL12-abundant reticular (CAR) cells, reside primarily around sinusoids (Morikawa et al., 2009; Omatsu et al., 2010) . CAR cells include bipotent progenitors of osteoblasts and adipocytes (Omatsu et al., 2010) . Ablation of CAR cells with diphtheria toxin (DT) depletes not only adipogenic and osteogenic progenitors, but also HSCs (Omatsu et al., 2010) . These data suggest that MSCs within the bone marrow are a cellular component of the HSC niche. Cells that express the Nestin-GFP transgene contain all of the CFU-Fs in mouse bone marrow Mé ndezFerrer et al., 2010) . These cells also express high levels of the HSC niche factors Cxcl12 and Stem cell factor (Scf) Mé ndez-Ferrer et al., 2010) . Nestin-CreER-expressing cells in adult bone marrow can contribute to osteoblasts and chondrocytes, though no quantification was provided regarding their CFU-F content or their level of contribution to new bone (Mé ndez-Ferrer et al., 2010) . Nestin-GFP is widely expressed by perivascular stromal cells in the bone marrow, but they express little endogenous Nestin, Nestin-CreER, or other Nestin transgenes (Ding et al., 2012) . Furthermore, Nestin-GFP + cells are heterogeneous, including both Nestin-GFP high cells that localize mainly around arterioles and Nestin-GFP low cells that localize mainly around sinusoids, raising questions about the distribution of HSC niche factors and MSCs among these cell populations .
During fetal development, Osterix (Osx) is expressed by cells that form bone marrow stroma, including perivascular, osteogenic, and adipogenic cells (Liu et al., 2013; Maes et al., 2010) . In adult bone marrow, Osx is expressed by a subset of CAR cells (Omatsu et al., 2010) , and fate mapping of these cells using OsxCreER revealed a transient contribution to osteoblasts (Park et al., 2012) . In contrast, Mx-1-Cre recombined widely among hematopoietic cells, PDGFRa + stromal cells, and CFU-Fs in the bone marrow, and these cells gave rise to most of the osteoblasts formed in adult bone marrow (Park et al., 2012) . The widespread marking of both hematopoietic and stromal cells by Mx-1-Cre meant that this marker could not be used to prospectively identify osteogenic progenitors.
Recently, we identified Leptin Receptor + (LepR + ) perivascular stromal cells that are the major source of Scf and Cxcl12 in the bone marrow Ding et al., 2012) . Conditional deletion of Scf with Lepr-Cre led to the depletion of quiescent HSCs (Ding et al., 2012; Oguro et al., 2013) and conditional deletion of Cxcl12 with Lepr-Cre led to HSC mobilization 1C , and 1D). The staining was in perivascular stromal cells that expressed the HSC niche factor Scf ( Figure 1C ). An antibody against the LepR extracellular domain stained in a pattern very similar to that of Tomato expression in Lepr-cre; tdTomato conditional reporter mice ( Figure 1D ). We identified sinusoids and arterioles based on VE-Cadherin (VE-Cad) staining, which bound endothelial cells in both sinusoids and arterioles, and SM22 staining, which specifically marked vascular smooth muscle around arterioles. Sinusoids were typically larger in diameter, less uniform, and thinner walled as compared to arterioles ( Figure 1E ). We observed LepR + cells around both sinusoids and arterioles throughout the bone marrow, though LepR + cells were much more prominent around some arterioles than others ( Figure 1E ). Nearly all the perisinusoidal LepR + cells were Scf-GFP + ; however, the periarteriolar LepR + cells, especially those densely surrounding larger arterioles, expressed less Scf-GFP ( Figure 1E ). The LepR + cells around arterioles were negative for SM22 or aSMA ( Figures 1E  and S1C ).
We observed little LepR antibody staining in CD45 + or Ter119 + hematopoietic cells ( Figure 1F ) or in VE-Cad + bone marrow endothelial cells (Figures 1A, 1E, and 1G) . The rare LepR antibody staining that was observed in these cells may reflect the expression of short isoforms of Lepr that lack the intracellular signaling domain (Ob-Ra, Ob-Rc, Ob-Rd, and Ob-Re) . These isoforms are somewhat more broadly expressed than the ObRb isoform, which encodes full-length LepR, including the intracellular signaling domain. It is this full-length isoform whose expression is marked by Lepr-cre. Little recombination was observed in macrophages ( Figure S1D ) or in other hematopoietic cells ( Figure 1M ) using Lepr-cre. Consistent with the lack of EYFP expression in bone-lining cells from 2-month-old Lepr-cre; EYFP reporter mice (Ding et al., 2012) , we were unable to detect LepR antibody staining in Col2.3-GFP + osteoblastic cells from cortical or trabecular bone in 2-month-old mice ( Figure 1H ). Neither Aggrecan + articular cartilage cells in the femur (knee joint; Figure 1I ) nor Perilipin + fat cells in the bone marrow ( Figure 1J) Figure 1E ). Nearly all LepR + cells expressed high levels of Cxcl12-DsRed and nearly all cells that expressed high levels of Cxcl12-DsRed expressed LepR ( Figure S1F ). Most LepR + cells expressed low levels of Nestin-GFP (Figures S1G and S1H), consistent with a recent report . Cells that expressed high levels of Nestin-GFP did not stain with either LepR or PDGFRa ( Figure S1H and PDGFRb (Komada et al., 2012) ( Figure 1N ). Figure 1N ). LepR + CD45
À

Ter119
À cells were heterogeneous for Sca-1 ( Figure 1N ), which is (Morikawa et al., 2009; Omatsu et al., 2010) .
LepR + Cells Are the Main Source of CFU-Fs in Bone Marrow
To assess CFU-F activity we enzymatically dissociated bone marrow cells and added them to adherent cultures at clonal density. Figure 2B shows the percentage of cells in each cell population sorted from unfractionated bone marrow cells (including both hematopoietic and stromal elements) that formed CFU-F colonies in culture. Figure 2C shows the percentage of cells in each cell population sorted from nonhematopoietic (CD45 À Ter119 À ) bone marrow stromal cells that formed CFU-F colonies in culture. In our experiments, 0.012% ± 0.002% of all enzymatically dissociated bone marrow cells ( Figure 2B ) or 1.3% ± 0.5% of CD45
À
Ter119
À bone marrow stromal cells formed CFU-F colonies ( Figure 2C ). Consistent with a prior study (Morikawa et al., 2009) Figure 2C ). Consistent with a previous study (Park et al., 2012) We also sorted individual LepR + cells from Lepr-cre; tdTomato; Col2.3-GFP mice into culture, allowed them to form CFU-F colonies, then expanded individual colonies, implanted the cells into denatured collagen sponges, transplanted them subcutaneously, and assessed the development of bony ossicles and hematopoiesis 8 weeks later. The presence of hematopoiesis was determined based on the presence of undifferentiated and differentiated erythroid, myeloid, and lymphoid cells in ossicle sections. Fourteen of twenty-five sponges did not form bone. Of the 11 that did form bone, we detected hematopoiesis in 8 ( Figures 2D and S2L-S2N ), 3 of which had abundant hematopoiesis that resembled bone marrow and 5 of which had smaller foci of hematopoietic cells distributed throughout each ossicle. In each case, we observed donor-derived (Park et al., 2012) . Bone marrow sections from Mx-1-cre; tdTomato mice showed widespread Tomato expression among hematopoietic cells, vascular cells, perivascular cells, and bonelining osteoblastic cells ( Figures S4B-S4D ). We found that 37% ± 25% of all CFU-F colonies formed by Mx-1-cre; tdTomato bone marrow cells were Tomato + ( Figure 2A ) and 46% ± 23% of all CD45 Figure S4A ). CFU-Fs rarely expressed NG2-CreER. Only 1.8% ± 1.0% of CFU-F colonies formed by bone marrow cells from NG2-creER; tdTomato reporter mice were Tomato + ( Figure 2A ). Tomato + cells accounted for 0.0026% ± 0.007% of all bone marrow cells in NG2-creER; tdTomato mice and 8.8% ± 3.6% of these cells stained positively for the MSC marker PDGFRa ( Figure S3A ). Only 9.8% ± 3.4% of Tomato + bone marrow cells in NG2-creER;
tdTomato; Scf-GFP mice were positive for Scf-GFP ( Figure S3A ). We observed almost no NG2-CreER-expressing cells among PDGFRa + cells or Scf-GFP + cells in the bone marrow ( Figures   S3B-S3D ).
In the bone marrow, NG2-creER labeled vascular smooth muscle cells ( Figure S3E ) and GFAP + glia associated with nerve fibers (Figure S3F) , chondrocytes, osteocytes, and rare osteoblasts (data not shown). NG2-antibody-stained cells also included Aggrecan + chondrocytes ( Figure S3G ), Col2.3-GFP + osteoblasts, and osteocytes ( Figure S3H ) in 2-month-old mice. Smooth muscle cells (Murfee et al., 2005) , peripheral nerve Schwann cells (Schneider et al., 2001 ), cartilaginous cells, and osteoblasts (Fukushi et al., 2003) have all been previously reported to express NG2. CFU-Fs also rarely expressed Nestin-creER. We did not detect any EYFP + CFU-F colonies formed by bone marrow cells from Nestin-creER; loxp-EYFP mice ( Figure 2A ). We observed labeling of rare cells associated with some arterioles in the bone marrow of Nestin-creER; loxp-EYFP mice ( Figure S4F ) consistent with previously published images (Mé ndez-Ferrer et al., 2010) . EYFP + cells accounted for 0.0012% ± 0.0005% of bone marrow cells and were nearly uniformly negative for PDGFRa ( Figure S4E ). When we aged Nestin-creER; loxp-EYFP mice for 11 months, we only detected rare EYFP + osteoblasts ( Figure S4F ), demonstrating that Nestin-CreERexpressing cells are not a significant source of bone in vivo. The observation that Nestin-GFP + cells included CFU-Fs, but
that Nestin-CreER-expressing cells did not ( Figures 2C and  S1H ), is consistent with our observation that different Nestin transgenes exhibit different expression patterns in the bone marrow (Ding et al., 2012) . Neither Nestin-GFP low nor Nestin-GFP high bone marrow cells appear to express endogenous Nestin (see microarray data in Mé ndez-Ferrer et al., 2010 and RNaseq data in Kunisaki et al., 2013) .
CFU-Fs were not neural crest-derived based on fate mapping with Wnt1-Cre (Chai et al., 2000; Echelard et al., 1994; Joseph et al., 2004) . We observed Tomato + nerve fibers and glia in the bone marrow of Wnt1-cre; tdTomato mice ( Figure S4H ), confirming that neural-crest-derived cells were marked in the bone marrow. In 2-to 4-month-old Wnt1-cre; tdTomato mice, 0.17% ± 0.29% of all Tomato + bone marrow cells ( Figure 2B) and 0.5% ± 0.5% of Tomato + CD45
) bone marrow cells expressing each marker that formed CFU-F colonies in culture (n = 3-11 mice/genotype from at least three independent experiments). Two-tailed Student's t tests were used to assess statistical significance. *p < 0.05, **p < 0.01, ***p < 0.001. (D (Figure 2A ). Tomato + cells in the bone marrow of 2-month-old Wnt1-cre; tdTomato reporter mice accounted for only 0.0017% ± 0.001% of bone marrow cells and were mostly negative for the MSC marker PDGFRa ( Figure S4G ). We aged Wnt1-cre; tdTomato mice for 5 months and observed rare Tomato + osteocytes ( Figure S4H ) but no Tomato + osteoblasts, indicating that these cells are not a significant source of bone-forming progenitors in young adult mice. Figures S2S and S2T ).
LepR
By 10 months of age, Tomato + cells contributed not only to bone-lining osteoblastic cells but also to osteocytes within the bone matrix (Figure 2Iiii ). The percentage of osteocytes that were Tomato + increased significantly with age, but much more rapidly within trabecular bone ( Figure 2M ). Tomato + cells represented 92% ± 7% of osteocytes in trabecular bone and 13% ± 5% of osteocytes in cortical bone at 14 months of age.
LepR + Cells Are a Major Source of Adipocytes in Adult Bone Marrow
Although LepR antibody did not detectably stain Perilipin + adipocytes ( Figures 1J and 3A) , most Perilipin + adipocytes in the bone marrow of 2-to 14-month-old Lepr-cre; tdTomato mice were Tomato + ( Figures 3A-3C ). The number of adipocytes in the bone marrow increased dramatically with age ( Figure 3B ). In contrast to those in the bone marrow, periosteal adipocytes (outside of the marrow cavity) were all negative for Tomato (Figure 3A) , suggesting a distinct cellular origin. LepR + cells are thus the major source of adipocytes in adult bone marrow.
Chondrogenesis is active during fetal development but largely inactive throughout adulthood (Raghunath et al., 2005) . In mice at P0.5 and at 2 months of age, we detected no Tomato expression among Aggrecan + chondrocytes in the femurs of Lepr-cre; tdTomato mice ( Figure 3D ) in spite of Tomato + osteoblasts and perivascular stromal cells adjacent to the growth plate (Figure 3E) . In 6-, 10-, and 14-month-old mice, we remained unable to detect Tomato + chondrocytes in articular cartilage or growth plate cartilage associated with femurs and tibias ( Figure S5A (B and C) Quantification of adipocyte number per 7 mm femur section (B) and the percentage of adipocytes that were Tomato + at each age (C) in Lepr-cre; tdTomato mice. Two-tailed Student's t tests were used to assess statistical significance. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001. n = 3-5 mice/ age from at least three independent experiments. Data represent mean ± SD. (D and E) Aggrecan + chondrocytes were not Tomato + in P0.5 (D) or 2-monthold (E) Lepr-cre; tdTomato mice (n = 3-5 mice/age from at least three independent experiments). Figure 4E ). Bone marrow cellularity and the number of Tomato + stromal cells in the bone marrow declined significantly 1 day after DT treatment but rebounded within 2 weeks (Figures 4F and 4G) . Consistent with our demonstration that LepR + stromal cells are critical for the maintenance of quiescent HSCs Ding et al., 2012; Oguro et al., 2013) , DT treatment depleted CD150 + CD48
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À LSK HSCs ( Figure 4H ).
Within 14 days of DT treatment, adipogenesis ( Figure 4J ) and osteogenesis ( Figure 4K ) increased profoundly in the bone marrow. Trabecular bone began filling up the marrow cavity, including the diaphysis ( Figure 4M ). Virtually all of the bone marrow adipocytes as well as the new Col2.3-GFP + osteoblasts
were Tomato + ( Figures 4J-4L ). The rate of bone formation, as measured by calcein labeling, was significantly higher in Leprcre; tdTomato; iDTR mice as compared to controls in both the metaphysis and the diaphysis ( Figures 4N and 4O ). LepR + cells did not give rise to Calcitonin + osteoclasts ( Figure 4P ). The regeneration of LepR + cells after ablation is thus associated with increased adipogenesis and osteogenesis.
LepR + Cells Are Activated by Irradiation to Form Osteoblasts and Adipocytes
We found that 25% ± 2.3% of the Tomato + stromal cells incorporated BrdU over a 2 week period after irradiation of Lepr-cre; tdTomato mice ( Figure 4Q ). In the next 2 weeks after irradiation, the percentage of Tomato + stromal cells that incorporated BrdU significantly increased to 35% ± 5.0% ( Figure 4Q ). At subsequent time points the percentage of Tomato + stromal cells that incorporated BrdU significantly declined ( Figure 4Q ). LepR + cells therefore divide transiently after irradiation. We observed a substantial increase in adipocyte frequency within the bone marrow after irradiation ( Figure 5A ) and 95% ± 3.0% of the Perilipin + adipocytes were Tomato + ( Figure 5B ). The frequency of osteoblasts undergoing cell death significantly increased 2 days after irradiation ( Figure 5C ). By 16 weeks after irradiation, most (65% ± 11%) osteoblasts derived from LepR + cells ( Figure 5D and Figure S6A ). Irradiation did not activate LepR expression in osteoblasts ( Figures S6B and S6C ). We remained unable to detect any contribution of LepR + cells to chondrocytes after irradiation ( Figure S6D and data not shown).
Regeneration of Fractured Bone by LepR + Cells
Two weeks after a break was created in the tibia of two-monthold Lepr-cre; tdTomato; Col2.3-GFP mice ( Figure 5E ), a substantial increase of Tomato + stromal cells was observed in the marrow cavity adjacent to the fracture site ( Figure 5F ). Col2.3-GFP + cells close to periosteum were mostly negative for Tomato expression, but much of the callus was composed of Tomato + cells ( Figure 5F ). Tomato + cells accounted for 46% ± 13% of Aggrecan + chondrocytes in the soft callus 2 weeks following the fracture (Figures 5I and 5J) . At 2 and 8 weeks after the fracture, 45% ± 5% and 85% ± 10% of Col2.3-GFP + osteoblasts
were Tomato + ( Figures 5F-5H ). In contrast, only 9%-14% of Col2.3-GFP + osteoblasts were Tomato + in the undamaged tibia of the same mice ( Figure 5H ). We confirmed by qRT-PCR that Ob-Rb mRNA was not expressed by newly generated osteoblasts at the tibia fracture site ( Figure S6E ). Most of the osteoblasts and osteocytes that persisted long-term at the fracture site thus arose from LepR + cells.
To investigate the contribution of LepR + cells to the repair of perforated cartilage, we performed a subchondral perforation in articular cartilage associated with the femur in the knee of (I and J) Quantification of adipocyte number per 7 mm femur section (I) and the percentage of adipocytes that were Tomato + (J) 14 days after DT treatment.
(K) Percentage of Col2.3-GFP + osteoblasts that were also Tomato + in enzymatically dissociated bone 2 weeks after DT treatment.
(L) Percentage of Col2.3-GFP + osteoblasts that were also Tomato + at metaphyseal (Met) and diaphyseal (Dia) bones 2 weeks after diphtheria toxin treatment. Statistical significance was always assessed using two-tailed Student's t tests. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001.
Cell Stem Cell Leptin Receptor Marks Bone Marrow MSCs
Lepr-cre; tdTomato mice. Eight weeks following perforation, the injured region of the cartilage was covered by Aggrecan + fibrocartilaginous tissues ( Figure 5K ) and 16% ± 11% of the Aggrecan + cells were positive for Tomato expression ( Figures  5K and 5L) Figure 6A ). Four weeks later, Tomato expression was observed in Col2.3-GFP + osteoblasts ( Figure 6B ), Perilipin + adipocytes ( Figure 6C ), and Aggrecan + chondrocytes in articular cartilage (which had been perforated by the injection; Figure 6D Pten is cell-autonomously required for the maintenance of HSCs (Kalaitzidis et al., 2012; Lee et al., 2010; Magee et al., 2012; Yilmaz et al., 2006; Zhang et al., 2006) and neural stem cells (Bonaguidi et al., 2011) . To assess the consequences of Pten deletion from MSCs, we generated Lepr-cre; Pten fl/fl mice. As expected, AKT (S473) phosphorylation increased in LepR + stromal cells isolated from Lepr-cre; Pten fl/fl mice ( Figure 7A ). Body mass and bone marrow cellularity were normal in Lepr-cre; Pten fl/fl mice ( Figures 7B and 7C ). However, we observed a more than 2-fold reduction in the frequencies of LepR Figure 7Q ). The expression of Runx2, a transcription factor required for osteogenesis (Komori et al., 1997; Otto et al., 1997) , was markedly reduced in LepR + stromal cells from Lepr-cre; Pten fl/fl as compared to control mice ( Figure 7R ). Pten deletion did not affect the percentage of CFU-F colonies that contained adipocytes versus osteoblastic cells ( Figure 7S ), but it did significantly increase the number of Figure 7T ). Pten is thus required by LepR + cells to promote osteogenesis and to restrain adipogenesis.
We did not detect a decline in the frequency of HSCs (Figure 7U) or colony-forming hematopoietic progenitors ( Figure 7W and Figures S7B-S7F Figures 7V and S7A) . Nonetheless, we did observe significant increases in the frequencies of HSCs ( Figure 7U ) and colony-forming hematopoietic progenitors ( Figure 7W ) in the spleen. These data suggest that Pten deletion from LepR + bone marrow stromal cells changed the bone marrow niche in a way that led to the mobilization of HSCs and colony-forming progenitors.
DISCUSSION
Our data support the conclusion that MSCs are an important component of the HSC niche Mé ndezFerrer et al., 2010; Omatsu et al., 2010; Sacchetti et al., 2007) Figures 1C, 1E , S1E, and S1F). The high expression of Cxcl12 ( Figure S1E ) and PDGFRa ( Figures 1L  and 1M ) by LepR + stromal cells indicates that these cells overlap strongly with CAR cells, which are also found primarily around sinusoids throughout the bone marrow (Omatsu et al., 2010; Sugiyama et al., 2006 (Cohen et al., 2001) , Pten fl/fl (Groszer et al., 2001 ), Scf-GFP (Ding et al., 2012) , Cxcl12-DsRed , Ubc-creER (Ruzankina et al., 2007 ), Rosa26-CAG-loxp-stop-loxp-tdTomato (Madisen et al., 2010 , Rosa26-loxp-stop-loxp-EYFP (Srinivas et al., 2001 ), Rosa26-loxp-stop-loxp-iDTR (Buch et al., 2005) , NG2-creER TM (Zhu et al., 2011) , Wnt-1-cre (Danielian and McMahon, 1996) , Nestin-GFP (Mignone et al., 2004) , Nestin-creER (Balordi and Fishell, 2007) , Mx-1-cre (Kü hn et al., 1995) , and Col2.3-GFP (Kalajzic et al., 2002) mice. To induce CreER activity, male mice (>2-month-old) were injected with 1 mg tamoxifen (Sigma) daily for 5 consecutive days followed by being fed ab libidum with chow containing 400 mg/kg tamoxifen for at least 2 weeks. To induce Mx-1-Cre expression, 2-month-old mice were injected with 10 mg poly-inosine:poly-cytosine (pIpC; Amersham)/20 g body mass every other day for 10 days. To treat mice with DT, we injected mice intraperitoneally with 100 ng of DT for 7 consecutive days. All mice were housed in the Animal Resource Center at the University of Texas Southwestern Medical Center (UTSW). All procedures were approved by the UTSW Institutional Animal Care and Use Committee. For methods related to flow cytometry, bone sectioning, qPCR, culture assay conditions, ossicle formation, irradiation, cell cycle analysis, calcein labeling, micro CT, western analysis, bone fracturing, intrafemoral injection, and subchondral perforation, see the Supplemental Experimental Procedures. 
